**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 54412-40-7 |Thallium (I) trifluoroacetylacetonate | 97% | unlisted |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T+
Risk Phrases: 26/28 33
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Very toxic by inhalation and if swallowed. Danger of cumulative
effects.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the
skin. Substance is readily absorbed through the skin.
Ingestion:
May be fatal if swallowed. May cause alopecia (loss of hair).
Inhalation:
May be fatal if inhaled.
Chronic:
May cause adverse nervous system effects including muscle tremors
and incoordination. May cause paralysis. May cause polyneuritis,
loss of hair, and endocrine system disorders.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes.
Ingestion:
Get medical aid immediately. Wash mouth out with water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on
skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 54412-40-7:
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 110 deg C Dec.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C12H10O4
Molecular Weight: 218.0676
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, acids.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen fluoride gas, thallium
fumes.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 54412-40-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Thallium (I) trifluoroacetylacetonate -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T+
Risk Phrases:
R 26/28 Very toxic by inhalation and if swallowed.
R 33 Danger of cumulative effects.
Safety Phrases:
S 13 Keep away from food, drink and animal feeding
stuffs.
S 28A After contact with skin, wash immediately with
plenty of water.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 54412-40-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 54412-40-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 54412-40-7 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 2/03/2000 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Barbituric Acid
| 67-52-7 |
|
3-Carboxypropyl triphenylphosphonium bromide, 97%
| 17857-14-6 |
|
Triphenylphosphine Hydroiodide
| 0-01-1 |
|
2-Amino-5-Nitrobenzoic Acid, 98%
| 616-79-5 |
|
Methyl 2,3-Dichlorobenzoate, 97%
| 2905-54-6 |
|
4-Bromobutyl triphenylphosphonium bromide, 97%
| 7333-63-3 |
|
4-Nitrobenzyl triphenylphosphonium bromide, 97%
| 2767-70-6 |
|
Cyanomethyl triphenylphosphonium chloride, 97%
| 4336-70-3 |
|
Triacontane, 98%
| 638-68-6 |
|
tert-Butoxycarbonylmethyl triphenylphosphonium bromide, 97%
| 59159-39-6 |
|
2,3,4,5,6-Pentabromobenzyl alcohol, 97%
| 79415-41-1 |
|
Acenaphthylene
| 208-96-8 |
|
5-Chlorothiophenesulphonyl chloride, 96%
| 2766-74-7 |
|
P-Bromophenoxyacetic Acid, 97%
| 1878-91-7 |
|
5-Bromothiophenesulphonyl chloride, 96%
| 55854-46-1 |
|
Methyl 5-Acetylsalicylate, 98%
| 16475-90-4 |
|
Barium acetate
| 543-80-6 |
|
Ibuprofen, 99%
| 15687-27-1 |
|
4,5-Dimethylthiophene-2-carboxaldehyde, 97%
| 0-01-1 |
|
(S)-1,2,4-Butanetriol, 95%, (99% e.e.)
| 42890-76-6 |
|
Ethyl (R)-4-cyano-3-hydroxybutanoate, 99%
| 141942-85-0 |
|
3-Methyl-2-furoic acid, 98%
| 4412-96-8 |
|
p-Acetaminobenzaldehyde, 97%
| 0-01-1 |
|
(S)-1,4-Dibromo-2-Butanol, 96%
| 64028-90-6 |
|
N,N'-Difluoro-2,2'-bipyridinium bis(tetrafluoroborate)
| 178439-26-4 |
|
4-Amino-6-methoxypyrimidine, 98%
| 0-01-1 |
|
Captopril, 98%
| 62571-86-2 |
|
Methyl (S)-(+)-3-Hydroxybutyrate, 99%
| 53562-86-0 |
|
2,5-Dimethoxybenzoic Acid, 98%
| 2785-98-0 |
|
Thallium (I) trifluoroacetylacetonate, 97%
| 54412-40-7 |
|
2-Methyl-2-Adamantanol, 98%
| 702-98-7 |
|
3-Noradmantanecarboxylic Acid, 98%
| 16200-53-6 |
|
Resorcin Blue
| 42249-61-6 |
|
Methylene violet 3RAX
| 4569-86-2 |
|
DL-allo-Threonine, 98%
| 0-01-1 |
|
1-Chloro-3,4-difluorobenzene, 99%
| 696-02-6 |
|
Methyl Red hydrochloride, reagent ACS
| 63451-28-5 |
|
Fast Sulphon Black F
| 3682-47-1 |
|
Methyl 5-nitro-2-furoate, 97%
| 1874-23-3 |
|
N-Aminohomopiperidine, 95%
| 5906-35-4 |
|
DOTAP mesylate
| 144139-73-1 |
|
Leishman stain
| 12627-53-1 |
|
1-Ethyl-2-iodobenzene, 98%
| 18282-40-1 |
|
Patent Blue V
| 3536-49-0 |
|
3-Methyl-1-penten-4-yn-3-ol, 99%
| 3230-69-1 |
|
Chelidamic Acid Monohydrate
| 138-60-3 |
|
N-Acetylethanolamine
| 142-26-7 |
|
Tetrahydrofuran-2,3,4,5-tetracarboxylic acid
| 26106-63-8 |
|
2,3,5,6-Tetramethyl-P-Phenylenediamine
| 3102-87-2 |
|
(S)-(+)-N-Alpha-Benzyl-N-Beta-BOC-L-Hydrazinoleucine
| 0-01-1 |
|
|